This compound is a pharmaceutical intermediate used in the synthesis of baloxavir marboxil, an antiviral agent. It is a polycyclic heterocyclic substance containing amide, ether, and aromatic ring functionalities.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1370250-39-7
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-
pharmaceutical intermediate
Battery Park City Authority
pharmaceutical intermediate
2-(2-aminoethoxy)-1,1-dimethoxyethane
pharmaceutical intermediate
1-Boc-4-piperidinecarboxaldehyde
pharmaceutical intermediate
2-(((1-(tert-Butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)-2-(2-((tert-butoxycarbonyl)amino)thiazol-4-yl)acetic acid
pharmaceutical intermediate
6-Chloro-2-methyl-3-pyridinecarboxylic acid
pharmaceutical intermediate
Voriconazole camphor sulfonate
pharmaceutical intermediate
(R)-7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
research compound
11-phenylmethoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
HJTRSKVIYMCKJU-UHFFFAOYSA-N
C1COCC2N1C(=O)C3=C(C(=O)C=CN3N2)OCC4=CC=CC=C4